StockData
HUTCHMED (China) Ltd logo

HUTCHMED (China) Ltd (HCM) stock

HCMNasdaqPharmaceutical PreparationsAlso trades as HMDCF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 5, 2026Score 5/30
$13.22−0.23 (-1.71%)

Close on Nov 20, 2026Market cap $2.31BP/E 5.1Yield –

HUTCHMED (China) free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

HUTCHMED (China)'s free cash flow for the twelve months ending Dec 31, 2019 was -$89.48M. For fiscal 2025 it was -$78.81M. The highest annual figure on record is $186.65M in fiscal 2023.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$78.81M–
FY2024Dec 31, 2024-$17.44M-109.3%
FY2023Dec 31, 2023$186.65M–
FY2022Dec 31, 2022-$305.26M–
FY2021Dec 31, 2021-$220.62M–
FY2020Dec 31, 2020-$70.02M–
FY2019Dec 31, 2019-$89.48M–
FY2018Dec 31, 2018-$39.21M–
FY2017Dec 31, 2017-$13.96M–
FY2016Dec 31, 2016-$13.90M–
FY2015Dec 31, 2015-$12.71M-374.5%
FY2014Dec 31, 2014$4.63M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2019Dec 31, 2019-$20.34M–
Q3 FY2019Sep 30, 2019-$35.25M–
Q2 FY2019Jun 30, 2019-$3.61M-131.4%
Q1 FY2019Mar 31, 2019-$30.28M–
Q4 FY2018Dec 31, 2018-$16.87M–
Q3 FY2018Sep 30, 2018-$1.67M–
Q2 FY2018Jun 30, 2018$11.48M–
Q1 FY2018Mar 31, 2018-$32.16M–

More HUTCHMED (China) figures

See a number that looks wrong?